SELECTED PUBLICATIONS
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Kang TG*, Lan X, Mi T, Chen H, Alli S, Lim S, Bhatara S, Vasandan AB, Ward G, Bentivegna S, Jang J, Spatz M, Han JW, Schlotmann BC, Jepersen JS, Derenzo C, Vogel P, Yu J, Baylin S, Jones P, Connell C, Gronback K, Youngblood B, Zebley C. Science. 2024 Oct. doi: 10.1126/science.adl4492. (*First author) PMID: 39388542
Epigenetic regulation of T cell exhaustion in cancer
Kang TG*, Johnson JT, Zebely CC, Youngblood B. Nat Rev Cancer. 2025 Oct. doi.org/10.1038/s41568-025-00883-y (*First author)
PMID: 41145849
Kang TG*, Kwon KW*, Kim K, Lee I, Kim MJ, Ha SJ, Shin SJ. Nat Communications. 2022 June. doi: 10.1038/s41467-022-30914-3. (*Co-first author) PMID: 35672321
Kwon KW*, Kang TG*, Lee JB, Choi E, Kim H, Park MC, Choi S, Kim K, Kim HW, Jeong SJ, Kim HR, Shin SJ, Ha SJ.
Nat Communications. 2025 Oct. doi: 10.1038/s41467-025-63930-0. (*Co-first author) PMID: 41053048
Kang TG*, Park HJ, Moon JH, Lee JH, Ha SJ. Immune Network. 2021 June. doi: 10.4110/in.2021.21.e23. (*First author)
PMID: 34277113
PUBLICATIONS (After Yonsei)
PEER-REVIEWED PUBLICATIONS (Before Yonsei)
Kang TG, Johnson J, Zebley CC, Youngblood B.
Epigenetic regulation of T cell exhaustion in cancer
Nature Reviews Cancer. 2026 Jan;26:46–61.
Kwon KW*, Kang TG*, Lee JB, Choi E, Kim H, Park MC, Choi SW, Kim KM, Kim HW, Jeong SJ, Kim HR, Kim HR, Shin SJ#, Ha SJ#.
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis
Nature Communications. 2025 Oct;16:8875. (*Co-first author)
Kang TG, Lan X, Mi T, Chen H, Alli S, Lim SE, Bhatara S, Vasanda AB, Ward G, Bentivegna S, Jang J, Spatz ML, Han JH, Schlotmann BC, Jespersen JS, Derenzo C, Vogel P, Yu J, Baylin S, Jones P, O'Connell C, Grønbæk K, Youngblood B, Zebley CC.
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy.
Science. 2024 Oct;386:eadl4492.
Kang TG#, Youngblood B#.
Type 1 diabetes: Advances in understanding and treatment 100 years after the discovery of insulin – Genetics and epigenetics of type 1 diabetes self-reactive T cells.
Cold Spring Harbor Perspectives in Medicine. 2024 Aug;14:a041586. (#Co-corresponding)
Mi T, Soerens AG, Alli S, Kang TG, Vasandan AB, Wang Z, Vezys V, Kimura S, Iacobucci I, Baylin SB, Jones PA, Hiner C, Mueller A, Goldstein H, Mullighan CG, Zebley CC, Masopust D, Youngblood B.
Conserved epigenetic hallmarks of T-cell aging during immunity and malignancy.
Nature Aging. 2024 Jun;4(8):1053-1063.
Choi D*, Kang TG*, Kim T*, Moon CW*, Choi M, Kim DH, Kim T, Oh Y, Jung S, Lee Y, Lee S, Hong J#, Ha SJ#.
Immortalized nanodendritic cells decorated with immune-checkpoint inhibitors for personalized cancer immunotherapy.
Nano Today. 2024. Mar;56:102237. (*Co-first author)
Kwon KW*, Kang TG*, Lee A, Jin SM, Lim YT, Shin SJ#, Ha SJ#.
Protective efficacy and immunogenicity of Rv0351/Rv3628 subunit vaccine formulated in different adjuvants against Mycobacterium tuberculosis infection.
Immune Network. 2023 Apr;23(2):e17. (*Co-first author)
Kang TG*, Kwon KW*, Kim K, Lee I, Kim MJ, Ha SJ#, Shin SJ#.
Viral coinfection-driven type I IFN signaling promotes tuberculosis immunopathogenesis by impeding the pulmonary influx of Th1 cells.
Nature Communications. 2022. Jun;13:3155. (*Co-first author)
Kang TG, Park HJ, Moon J, Lee JH, Ha SJ.
Enhancing CCL3 in the tumor microenvironment facilitates T cell responses and improves the efficacy of anti-PD-1 therapy.
Immune Network. 2021 Jun;21(3):e23.
Lim S, Lee JA, Koo JH, Kang TG, Ha SJ, Choi JM.
Cell type preference of a novel human derived cell-permeable peptide dNP2 and TAT in murine splenic immune cells.
PLoS One. 2016 May;11(5):e0155689.